TUBA3D

gene
On this page

Also known as H2-ALPHA

Summary

TUBA3D (tubulin alpha 3d, HGNC:24071) is a protein-coding gene on chromosome 2q21.1, encoding Tubulin alpha-3D chain (P0DPH8). Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. It is a selective cancer dependency (DepMap: 16.4% of cell lines).

This gene encodes a member of the alpha tubulin family. Tubulin is a major component of microtubules, which are composed of alpha- and beta-tubulin heterodimers and microtubule-associated proteins in the cytoskeleton. Microtubules maintain cellular structure, function in intracellular transport, and play a role in spindle formation during mitosis.

Source: NCBI Gene 113457 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): keratoconus 9 (Limited, GenCC)
  • Clinical variants (ClinVar): 3 total
  • Phenotypes (HPO): 5
  • Cancer dependency (DepMap): dependent in 16.4% of screened cell lines
  • MANE Select transcript: NM_080386

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24071
Approved symbolTUBA3D
Nametubulin alpha 3d
Location2q21.1
Locus typegene with protein product
StatusApproved
AliasesH2-ALPHA
Ensembl geneENSG00000075886
Ensembl biotypeprotein_coding
OMIM617878
Entrez113457

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000321253, ENST00000409047

RefSeq mRNA: 1 — MANE Select: NM_080386 NM_080386

CCDS: CCDS33290

Canonical transcript exons

ENST00000321253 — 5 exons

ExonStartEnd
ENSE00001957482131476119131476202
ENSE00002481699131482552131482934
ENSE00002489437131478164131478386
ENSE00002526860131480069131480749
ENSE00003555115131479308131479456

Expression profiles

Bgee: expression breadth ubiquitous, 130 present calls, max score 99.02.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3667 / max 360.8680, expressed in 5 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
225490.32505
2023930.04183

Top tissues by expression

132 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right testisUBERON:000453499.02gold quality
left testisUBERON:000453398.82gold quality
testisUBERON:000047398.09gold quality
heart left ventricleUBERON:000208493.07gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099189.39gold quality
apex of heartUBERON:000209888.38gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047384.02gold quality
heartUBERON:000094881.68gold quality
fallopian tubeUBERON:000388976.27gold quality
right atrium auricular regionUBERON:000663175.52gold quality
left uterine tubeUBERON:000130373.74gold quality
right uterine tubeUBERON:000130270.62gold quality
prostate glandUBERON:000236770.36gold quality
body of uterusUBERON:000985370.03gold quality
endocervixUBERON:000045869.31gold quality
smooth muscle tissueUBERON:000113566.46gold quality
cerebellar hemisphereUBERON:000224565.82gold quality
cerebellumUBERON:000203765.76gold quality
cerebellar cortexUBERON:000212965.75gold quality
right hemisphere of cerebellumUBERON:001489065.35gold quality
stromal cell of endometriumCL:000225565.15gold quality
myometriumUBERON:000129665.05gold quality
uterine cervixUBERON:000000264.56gold quality
left ovaryUBERON:000211963.70gold quality
Brodmann (1909) area 9UBERON:001354063.60gold quality
right ovaryUBERON:000211862.84gold quality
ovaryUBERON:000099262.68gold quality
ectocervixUBERON:001224962.51gold quality
right lobe of thyroid glandUBERON:000111962.28gold quality
lymph nodeUBERON:000002962.16gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-GEOD-134144yes1175.93
E-GEOD-124263yes808.09
E-ANND-3yes11.32

Regulation

Is transcription factor: no

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 16.4% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 1)

  • TUBA3D is a new gene that causes keratoconus.The c.31 C > T (Gln11stop) and c.201insTT (Val68Leufs*2) mutations lead to TUBA3D degradation and higher matrix metalloproteinases expression in cornea fibroblasts. (PMID:29051577)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotuba7lENSDARG00000104643
rattus_norvegicusTuba3aENSRNOG00000031707
drosophila_melanogasteralphaTub84BFBGN0003884
drosophila_melanogasteralphaTub84DFBGN0003885

Paralogs (23): TUBG2 (ENSG00000037042), TUBE1 (ENSG00000074935), TUBB1 (ENSG00000101162), TUBB4A (ENSG00000104833), TUBD1 (ENSG00000108423), TUBA1B (ENSG00000123416), TUBA4A (ENSG00000127824), TUBG1 (ENSG00000131462), TUBB2A (ENSG00000137267), TUBB2B (ENSG00000137285), TUBA3E (ENSG00000152086), TUBA1A (ENSG00000167552), TUBA1C (ENSG00000167553), TUBB8B (ENSG00000173213), TUBB6 (ENSG00000176014), TUBAL3 (ENSG00000178462), TUBA8 (ENSG00000183785), TUBB4B (ENSG00000188229), TUBB (ENSG00000196230), TUBA3C (ENSG00000198033), TUBA4B (ENSG00000243910), TUBB3 (ENSG00000258947), TUBB8 (ENSG00000261456)

Protein

Protein identifiers

Tubulin alpha-3D chainP0DPH8 (reviewed: P0DPH8)

Alternative names: Alpha-tubulin 3D

All UniProt accessions (2): P0DPH8, Q1ZYQ1

UniProt curated annotations — full annotation on UniProt →

Function. Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin.

Subunit / interactions. Dimer of alpha and beta chains. A typical microtubule is a hollow water-filled tube with an outer diameter of 25 nm and an inner diameter of 15 nM. Alpha-beta heterodimers associate head-to-tail to form protofilaments running lengthwise along the microtubule wall with the beta-tubulin subunit facing the microtubule plus end conferring a structural polarity. Microtubules usually have 13 protofilaments but different protofilament numbers can be found in some organisms and specialized cells.

Subcellular location. Cytoplasm. Cytoskeleton.

Tissue specificity. Expressed in the cornea, sclera, and peripheral blood.

Post-translational modifications. Some glutamate residues at the C-terminus are polyglutamylated, resulting in polyglutamate chains on the gamma-carboxyl group. Polyglutamylation plays a key role in microtubule severing by spastin (SPAST). SPAST preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity by SPAST increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold. Glutamylation is also involved in cilia motility. Some glutamate residues at the C-terminus are monoglycylated but not polyglycylated due to the absence of functional TTLL10 in human. Monoglycylation is mainly limited to tubulin incorporated into cilia and flagella axonemes, which is required for their stability and maintenance. Flagella glycylation controls sperm motility. Both polyglutamylation and monoglycylation can coexist on the same protein on adjacent residues, and lowering glycylation levels increases polyglutamylation, and reciprocally. Acetylation of alpha chains at Lys-40 is located inside the microtubule lumen. This modification has been correlated with increased microtubule stability, intracellular transport and ciliary assembly. Methylation of alpha chains at Lys-40 is found in mitotic microtubules and is required for normal mitosis and cytokinesis contributing to genomic stability. Nitration of Tyr-450 is irreversible and interferes with normal dynein intracellular distribution. Undergoes a tyrosination/detyrosination cycle, the cyclic removal and re-addition of a C-terminal tyrosine residue by the enzymes tubulin tyrosine carboxypeptidase (MATCAP1/KIAA0895L, VASH1 or VASH2) and tubulin tyrosine ligase (TTL), respectively. Tyrosination promotes microtubule interaction with CAP-Gly domain-containing proteins such as CLIP1, CLIP2 and DCTN1. Tyrosination regulates the initiation of dynein-dynactin motility via interaction with DCTN1, which brings the dynein-dynactin complex into contact with microtubules. In neurons, tyrosinated tubulins mediate the initiation of retrograde vesicle transport. Detyrosination is involved in metaphase plate congression by guiding chromosomes during mitosis: detyrosination promotes interaction with CENPE, promoting pole-proximal transport of chromosomes toward the equator. Detyrosination increases microtubules-dependent mechanotransduction in dystrophic cardiac and skeletal muscle. In cardiomyocytes, detyrosinated microtubules are required to resist to contractile compression during contraction: detyrosination promotes association with desmin (DES) at force-generating sarcomeres, leading to buckled microtubules and mechanical resistance to contraction.

Disease relevance. Keratoconus 9 (KTCN9) [MIM:617928] An autosomal dominant form of keratoconus, a common degenerative corneal disease characterized by progressive, non-inflammatory thinning of the corneal stroma, corneal ectasia, and cone-shaped corneal protrusion that results in reduced vision. The disease is caused by variants affecting the gene represented in this entry.

Domain organisation. The MREC motif may be critical for tubulin autoregulation.

Similarity. Belongs to the tubulin family.

RefSeq proteins (1): NP_525125* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000217TubulinFamily
IPR002452Alpha_tubulinFamily
IPR003008Tubulin_FtsZ_GTPaseDomain
IPR008280Tub_FtsZ_CHomologous_superfamily
IPR017975Tubulin_CSConserved_site
IPR018316Tubulin/FtsZ_2-layer-sand-domDomain
IPR023123Tubulin_CHomologous_superfamily
IPR036525Tubulin/FtsZ_GTPase_sfHomologous_superfamily
IPR037103Tubulin/FtsZ-like_CHomologous_superfamily

Pfam: PF00091, PF03953

Catalyzed reactions (Rhea), 1 shown:

  • GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)

UniProt features (20 total): binding site 9, modified residue 4, chain 2, site 1, sequence variant 1, sequence conflict 1, short sequence motif 1, active site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0DPH8-F191.570.82

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (2): 450 (involved in polymerization); 254

Ligand- & substrate-binding residues (9): 179; 206; 228; 11; 71; 71; 140; 144; 145

Post-translational modifications (4): 40, 282, 439, 450

Function

Pathways and Gene Ontology

Reactome pathways

86 pathways

IDPathway
R-HSA-1445148Translocation of SLC2A4 (GLUT4) to the plasma membrane
R-HSA-190840Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
R-HSA-190861Gap junction assembly
R-HSA-2132295MHC class II antigen presentation
R-HSA-2467813Separation of Sister Chromatids
R-HSA-2500257Resolution of Sister Chromatid Cohesion
R-HSA-3371497HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
R-HSA-380320Recruitment of NuMA to mitotic centrosomes
R-HSA-389957Prefoldin mediated transfer of substrate to CCT/TriC
R-HSA-389960Formation of tubulin folding intermediates by CCT/TriC
R-HSA-389977Post-chaperonin tubulin folding pathway
R-HSA-437239Recycling pathway of L1
R-HSA-5610787Hedgehog ‘off’ state
R-HSA-5620920Cargo trafficking to the periciliary membrane
R-HSA-5620924Intraflagellar transport
R-HSA-5626467RHO GTPases activate IQGAPs
R-HSA-5663220RHO GTPases Activate Formins
R-HSA-6807878COPI-mediated anterograde transport
R-HSA-6811434COPI-dependent Golgi-to-ER retrograde traffic
R-HSA-6811436COPI-independent Golgi-to-ER retrograde traffic
R-HSA-68877Mitotic Prometaphase
R-HSA-8852276The role of GTSE1 in G2/M progression after G2 checkpoint
R-HSA-8955332Carboxyterminal post-translational modifications of tubulin
R-HSA-9609690HCMV Early Events
R-HSA-9609736Assembly and cell surface presentation of NMDA receptors
R-HSA-9619483Activation of AMPK downstream of NMDARs
R-HSA-9646399Aggrephagy
R-HSA-9648025EML4 and NUDC in mitotic spindle formation
R-HSA-9668328Sealing of the nuclear envelope (NE) by ESCRT-III
R-HSA-983189Kinesins

MSigDB gene sets: 163 (showing top): REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, REACTOME_MEMBRANE_TRAFFICKING, PATIL_LIVER_CANCER, UEDA_PERIFERAL_CLOCK, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6, SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN, GOBP_MITOTIC_CELL_CYCLE, REACTOME_GAP_JUNCTION_ASSEMBLY, REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES, IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM, GOCC_CILIUM, TOMIDA_METASTASIS_UP, GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON

GO Biological Process (4): microtubule cytoskeleton organization (GO:0000226), mitotic cell cycle (GO:0000278), cytoskeleton organization (GO:0007010), microtubule-based process (GO:0007017)

GO Molecular Function (5): structural constituent of cytoskeleton (GO:0005200), GTP binding (GO:0005525), hydrolase activity (GO:0016787), metal ion binding (GO:0046872), nucleotide binding (GO:0000166)

GO Cellular Component (5): cytoplasm (GO:0005737), microtubule (GO:0005874), cilium (GO:0005929), microtubule cytoskeleton (GO:0015630), cytoskeleton (GO:0005856)

Reactome top-level categories

Rollup of top-15 pathways:

CategoryPathways
Mitotic Prometaphase2
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding2
Assembly of the 9+0 primary cilium2
RHO GTPase Effectors2
Golgi-to-ER retrograde transport2
Membrane Trafficking1
Transport of connexons to the plasma membrane1
Gap junction trafficking1
Adaptive Immune System1
Mitotic Anaphase1
Cellular responses to stress1
Protein folding1
L1CAM interactions1
Signaling by Hedgehog1
ER to Golgi Anterograde Transport1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoskeleton organization2
cytoskeleton2
microtubule-based process1
cell cycle1
mitotic nuclear division1
organelle organization1
cellular process1
structural molecule activity1
guanyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
catalytic activity1
cation binding1
nucleoside phosphate binding1
heterocyclic compound binding1
intracellular anatomical structure1
cellular anatomical structure1
microtubule cytoskeleton1
polymeric cytoskeletal fiber1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1
intracellular membraneless organelle1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A5A6J1, P02550, P02552, P05213, P05214, P06603, P06604, P06605, P08537, P09644, P0DPH7, P0DPH8, P18258, P18288, P30436, P34690, P36220, P41383, P52273, P68360, P68361, P68362, P68363, P68365, P68366, P68367, P68368, P68369, P68370, P68373, P81947, P81948, Q06331, Q28IX8, Q2HJ86, Q2XVP4, Q32KN8, Q3ZCJ7, Q4R538, Q52PV9

Diamond homologs: A0AAL4, A5A6J1, B9DGT7, B9DHQ0, O22347, O22348, O22349, P02550, P02552, P04105, P04106, P05213, P05214, P06603, P06604, P08537, P09204, P09205, P09243, P0DPH7, P0DPH8, P10872, P10873, P11139, P11237, P11480, P11481, P12543, P14640, P14641, P14642, P18258, P18288, P22275, P28268, P28287, P28752, P29511, P30436, P32255

SIGNOR signaling

3 interactions.

AEffectBMechanism
“Elongator complex”“up-regulates activity”TUBA3Dacetylation
TUBA3Dup-regulatesNeuron_migration
ATAT1“up-regulates quantity by stabilization”TUBA3Dacetylation

Disease & clinical

Clinical variants and AI predictions

ClinVar

3 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign1
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

816 predictions. Top by Δscore:

VariantEffectΔscore
2:131478155:T:TAacceptor_gain1.0000
2:131478160:A:AGacceptor_gain1.0000
2:131478161:C:Gacceptor_gain1.0000
2:131478162:A:AGacceptor_gain1.0000
2:131478162:A:Cacceptor_loss1.0000
2:131478162:AGC:Aacceptor_gain1.0000
2:131478162:AGCGC:Aacceptor_gain1.0000
2:131478163:G:GAacceptor_gain1.0000
2:131478163:GC:Gacceptor_gain1.0000
2:131478163:GCG:Gacceptor_gain1.0000
2:131478163:GCGC:Gacceptor_gain1.0000
2:131478163:GCGCG:Gacceptor_gain1.0000
2:131478337:C:Tdonor_gain1.0000
2:131478383:GTCG:Gdonor_gain1.0000
2:131478386:GGTA:Gdonor_loss1.0000
2:131478387:G:GGdonor_gain1.0000
2:131478387:GTAG:Gdonor_loss1.0000
2:131478388:T:Gdonor_loss1.0000
2:131479303:T:Aacceptor_gain1.0000
2:131479306:A:AGacceptor_gain1.0000
2:131479306:A:Gacceptor_loss1.0000
2:131479306:AGAT:Aacceptor_gain1.0000
2:131479307:G:GTacceptor_gain1.0000
2:131479307:GA:Gacceptor_gain1.0000
2:131479307:GAT:Gacceptor_gain1.0000
2:131479307:GATG:Gacceptor_gain1.0000
2:131479307:GATGA:Gacceptor_gain1.0000
2:131479452:AACTG:Adonor_gain1.0000
2:131479453:ACTG:Adonor_gain1.0000
2:131479454:CTG:Cdonor_gain1.0000

AlphaMissense

2955 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1001305595 (2:131477504 C>G), RS1002819666 (2:131477999 T>C), RS1002902032 (2:131475038 G>A), RS1002974080 (2:131474709 C>A,G), RS1003667640 (2:131479714 C>A,T), RS1003773994 (2:131479033 T>C), RS1004723294 (2:131479906 G>A,C), RS1004823708 (2:131475343 T>G), RS1005397689 (2:131483102 T>C), RS1005421286 (2:131476278 T>C), RS1005677070 (2:131476533 A>G), RS1005843301 (2:131481284 T>A), RS1007068686 (2:131483206 T>C), RS1007186242 (2:131477220 T>C), RS1007214433 (2:131482415 G>A)

Disease associations

OMIM: gene MIM:617878 | disease phenotypes: MIM:617928

GenCC curated gene-disease

DiseaseClassificationInheritance
keratoconus 9LimitedUnknown

Mondo (1): keratoconus 9 (MONDO:0054771)

Orphanet (0):

HPO phenotypes

5 total (5 of 5 shown, HPO-id order):

HPOTerm
HP:0000006Autosomal dominant inheritance
HP:0000563Keratoconus
HP:0003621Juvenile onset
HP:0007663Reduced visual acuity
HP:0100689Decreased corneal thickness

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
Estradiolaffects binding, increases expression, affects expression, increases reaction2
aristolochic acid Idecreases expression1
methyleugenoldecreases expression1
sulforaphaneaffects binding1
cupric chloridedecreases expression1
cupric oxidedecreases expression1
phenethyl isothiocyanateaffects binding1
CGP 52608affects binding, increases reaction1
bromovaninincreases expression1
Zoledronic Aciddecreases expression1
Acetaminophendecreases expression1
Atrazineincreases expression1
Calcitriolincreases expression, affects cotreatment1
Cocainedecreases expression1
Demecolcinedecreases expression1
Hydrogen Peroxideaffects expression1
Dihydrotestosteroneincreases expression1
Testosteroneaffects cotreatment, increases expression1
Vincristinedecreases expression1
Aflatoxin B1decreases methylation1
Okadaic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Associated diseases: keratoconus 9
  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): keratoconus 9